The company is advancing its PYX-201 program, which is undergoing a Phase 1 trial targeting patients with solid tumors that express the fibronectin EDB, with 80 subjects already dosed. The focus ...

Pyxis Oncology had cash and cash equivalents, including restricted cash and short-term investments of $157.2 million. Pyxis says that its current cash, cash equivalents, and short-term investments ...

Blockstream 联合创始人兼首席执行官 Adam Back 博士是一位英国密码学家和计算机科学家，他因在 1997 年发明了 Hashcash 而闻名，这后来成为了比特币工作 ...